Tibolone

Tibolone.svg

Synthetic steroid used in hormone replacement therapy

Engineered Monoclonal Antibodies

Diagram of engineered monoclonal antibodies

Engineered monoclonal antibodies are a class of biological therapies that are designed to target specific antigens on the surface of cells. These antibodies are produced using recombinant DNA technologies and are used in the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases.

Structure and Function

Monoclonal antibodies are composed of two identical heavy chains and two identical light chains, forming a Y-shaped molecule. The tips of the "Y" contain the antigen-binding sites, which are highly specific to the target antigen. This specificity allows monoclonal antibodies to bind to their target with high affinity, blocking or modulating the function of the antigen.

Types of Engineered Monoclonal Antibodies

There are several types of engineered monoclonal antibodies, each designed for specific therapeutic purposes:

• Chimeric antibodies: These antibodies are composed of murine (mouse) variable regions and human constant regions. They are less immunogenic than fully murine antibodies.

• Humanized antibodies: These antibodies are mostly human, with only the antigen-binding sites derived from murine sources. This reduces the risk of immune reactions.

• Fully human antibodies: These are entirely human in origin, produced using transgenic mice or phage display technologies.

• Bispecific antibodies: These antibodies are engineered to bind two different antigens simultaneously, offering unique therapeutic mechanisms.

Applications in Medicine

Engineered monoclonal antibodies have revolutionized the treatment of many diseases:

• Cancer therapy: Monoclonal antibodies can target specific tumor antigens, leading to direct tumor cell killing or recruitment of immune cells to attack the tumor.

• Autoimmune diseases: By targeting specific components of the immune system, monoclonal antibodies can reduce inflammation and tissue damage in diseases such as rheumatoid arthritis and multiple sclerosis.

• Infectious diseases: Monoclonal antibodies can neutralize pathogens or their toxins, providing passive immunity or enhancing the host's immune response.

Production

The production of engineered monoclonal antibodies involves several steps:

1. Antigen identification: The target antigen is identified and characterized. 2. Hybridoma technology: B cells from immunized animals are fused with myeloma cells to create hybridomas that produce the desired antibody. 3. Recombinant DNA technology: Genes encoding the antibody are cloned and expressed in suitable host cells, such as Chinese hamster ovary cells. 4. Purification and formulation: The antibodies are purified and formulated for clinical use.

Challenges and Future Directions

While engineered monoclonal antibodies have shown great promise, there are challenges such as high production costs, potential for immune reactions, and the development of resistance. Ongoing research aims to improve antibody design, reduce immunogenicity, and enhance therapeutic efficacy.

Related Pages

• Monoclonal antibody therapy
• Biopharmaceutical
• Immunotherapy
• Hybridoma technology

Tibolone is a synthetic steroid used primarily in hormone replacement therapy (HRT) for postmenopausal women. It is marketed under various brand names, including Livial and Tibofem. Tibolone exhibits tissue-specific effects, acting as an estrogen, progestogen, and androgen depending on the target tissue.

Pharmacology

Tibolone is metabolized into three active metabolites that contribute to its tissue-specific effects. These metabolites include:

• 3α-hydroxytibolone
• 3β-hydroxytibolone
• Δ4-tibolone

The metabolites exhibit varying affinities for estrogen, progesterone, and androgen receptors, which allows tibolone to mimic the effects of these hormones in different tissues.

Medical Uses

Tibolone is primarily used for the treatment of symptoms associated with menopause, such as hot flashes, vaginal atrophy, and osteoporosis. It is also used to prevent postmenopausal osteoporosis.

Menopausal Symptoms

Tibolone is effective in alleviating common menopausal symptoms, including hot flashes and night sweats. It also helps in maintaining vaginal health by reducing vaginal dryness and atrophy.

Osteoporosis

Tibolone has been shown to have a positive effect on bone mineral density, making it a useful option for the prevention and treatment of osteoporosis in postmenopausal women.

Side Effects

Common side effects of tibolone include:

• Breast tenderness
• Weight gain
• Abdominal pain
• Vaginal bleeding

Serious side effects may include an increased risk of breast cancer, stroke, and cardiovascular disease.

Contraindications

Tibolone is contraindicated in individuals with:

• Breast cancer
• Endometrial cancer
• Liver disease
• Thromboembolic disorders

Mechanism of Action

Tibolone's mechanism of action involves its conversion into active metabolites that interact with estrogen, progesterone, and androgen receptors. This interaction results in tissue-specific effects that help alleviate menopausal symptoms and prevent osteoporosis.

History

Tibolone was developed in the 1960s and has been used in clinical practice since the 1980s. It is available in many countries worldwide and is commonly prescribed for hormone replacement therapy in postmenopausal women.

See Also

• Hormone replacement therapy
• Menopause
• Osteoporosis
• Estrogen
• Progestogen
• Androgen

This article is a stub related to medicine. You can help WikiMD by expanding it!